$IMMB SWEET EMAILER JUST OUT IMMB Special Update Hot

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

[b]$IMMB SWEET EMAILER JUST OUT >> IMMB Special Update

[/b]

Hot news just came out fron IMMB and guess what, the guy that just was put on the board is a stud ! Also the company mentioned it brought him in as part of the plans to go to NASDAQ. not the exact wording, but here check out today's press and good luck.

$IMMB NASDAQ Uplisting mentioned in PR http://finance.yahoo.com/news/immunotech-labo...00904.html

This type of exposure could be huge in the longterm.

Thomas Hitman Hearns - http://www.youtube.com/watch?v=4c2nwrvTORU&am...e=youtu.be

Sugar Ray Leonad - http://www.youtube.com/watch?v=TqAwgDEDVJ0&am...e=youtu.be

Cory Feldman Link - http://www.youtube.com/watch?v=QyH6tVKBUjg

Cleve Hall Link - http://www.youtube.com/watch?v=ZLcQ12GF0ao

Happy Trading

Video Link  first interview with Bo Linton -   http://www.youtube.com/watch?v=uCjNAf30aeo

Testimonials - www.lifechoicemx.com

Don't be greedy forward this email to a friend.  Can you imagine if everybody sent this email to 5-10 friends how happy your friends would be

A Breakthrough Treatment For HIV, Cancer and Aids Can Make Investors A Nice Profit.

Add Immunotech Laboratories to your watchlist right away.

Ticker IMMB

Hello new and existing subscribers.  Today we are profiling Immunotech Laboratorires ticker IMMB.  The Company produces treatments for patients that have HIV, Aids, Cancer and Hepatitis C.  Please note this is not just some 1 day profile deal here, PSPicks and several others are going to be profiling this for at least a month!

The Float Is About 1,000,000 Shares so this can really fly!

FDA Approval

IMMB just announced an LOI with an International Bio-Tech partner for USA clinical trials.  In other words they are moving towards FDA Approval.  Have you ever seen what happens to a stock after FDA Approval?  Stocks tend to shoot up big time when that happens.  I've seen some companies shoot up for 5000% or higher gains.  Now that would be nice huh?

Company Has Patented Technology

IMMB's  treatments are already patented.   Immunotech (IMMB) appears to be ahead of its competition in many aspects.

Check out the company website immunotechlab.com for detailed information

Treatments And Testimonials Already

When you are making profits trading IMMB you can really feel good about it because they are actually helping to treat these horrible diseases.

Go check out LifeChoiceMX.com right away.  This is a treatment center that is treating patients in Mexico right now with the immunotherapies.  There are actual video tesimonials of people that have been treated and cured.   Were not just talking about a potential treatment, these guys are actually doing it.  The company has also said they are planning on opening centers in Africa and Bulgaria.

Revenues In The Billions

There are 30 Million HIV Patients in Africa alone.  Let alone the rest of the world.  IMMB has indicated that they will be in the Billions in terms of revenues once approved.

Like I said we are going to be covering this one for a while, This is just the start.  Please start your research in these places

Company Website - ImmunotechLab.com

Treatment Center In Mexico - lifechoicemx.comt

Latest Press - http://finance.yahoo.com/news/immunotech-labo...00154.html

More To Come Good Luck !

***********************

Disclaimer

***********************

Notice, by subscribing to our newsletter or browsing our website you agree to the

following terms / conditions.

This marketing report, release, and/or advertisement is a commercial advertisement and

is only to be used for for general information purposes. Never invest in any security

featured on our site, emails, print and videos unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or

joining our email list.

PSPICKS.com, its employees and affiliates are not a Registered Investment Advisors,

Broker Dealers, or a member of any association for other research providers in any jurisdiction whatsoever.

PSPICKS.com is often times compensated to feature certain companies. Payments

typically come from a Third Party holding shares of a Company.  The third parties may

have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1933 Securities Act. Any compensation constitutes a conflict of interest as to our ability

to remain objective in our communication regarding the profiled companies.

Any Compensation for marketing is disclosed at the bottom of this email.

PSPICKS.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisements should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact

the share price of the profiled company negatively. PSPICKS.com affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the share price of the security.

Release of Liability: Through use of this website, and/or ad campaign viewing or using

you agree to hold PSPICKS.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you

may incur. The information contained herein is based on sources that PSPICKS assume

to be reliable, but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. PSPICKS.com encourages readers and investors to supplement the information in these reports with independent research

and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and PSPICKS.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. FURTHERMORE, by accessing, viewing, or using

the website, communications, and advertisements originating from PSPICKS.com you

agree that PSPICKS.com, its owners, officers, directors, contractors, employees, and affiliates are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that PSPICKS.com, its owners, officers, directors, contractors, employees, and affiliates shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to

these sites are provided for your convenience only. PSPICKS.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others

from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold PSPICKS.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website, email, advertisements is at your sole risk. PSPICKS.com disclaims all warranties of any kind, express or implied.

Third Party Web Sites and Information

PSPICKS.com and newsletter may provide hyperlinks to third party websites or access to third party content. PSPICKS.com does not control, endorse, or guarantee content found in such sites. You agree that PSPICKS.com is not responsible for any content, associated

links, resources, or services associated with a third party site. You further agree that PSPICKS.com shall not be liable for any loss or damage of any sort associated with your

use of third party content. Links and access to these sites are provided for your

convenience only None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead PSPICKS.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. PSPICKS.com is compliant with the Can Spam Act of 2003. PSPICKS.com does not offer such advice or analysis, and PSPICKS.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.

PSPICKS.com website, emails, and or advertisements may have forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of

risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”,

“estimates”, “believes”, “understands”, or that by statements indicating certain actions

“may”, “could”, or “might” occur. Understand there is no guarantee past performance

will be indicative of future results.

In preparing our publications, PSPICKS.com has relied upon information supplied by its customers, and press releases, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this

website. Rather, investors should use the information contained in this website as a

starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, PSPICKS.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement.

PSPICKS.com is not responsible for any claims made by the companies advertised herein, nor is PSPICKS.com responsible for any other promotional firm, its program or its structure.

PSPicks expects to be compensated up to $75,000 for marketing services by Third Party.

Immunotech Laboratories Inc (IMMB) Stock Research Links

IMMB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mitrade EU Enhances Investor Safety with New Insurance

Updated Category News Views 3

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Continue Reading
Lundbeck's Bexicaserin Insights Rock Epilepsy Congress

Updated Category News Views 4

Breaking Down Bexicaserin's Dual Action Seems like Lundbeck's playing the long game with bexicaserin, and boy, are they shaking things up at the European Epilepsy Congress. This isn't your usual sit-back-and-watch situation. They're putting bexicaserin's dual mode of action under a magnifying glass, aiming to hit both sides of the brain's seesaw by increasing inhibitory...

Continue Reading
Telit Cinterion Secures U.S. Manufacturing with PA Facility

Updated Category News Views 1

Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...

Continue Reading
RealityMine Appoints CPO Amidst Strong Growth Momentum

Updated Category News Views 4

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 3

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
Shell Seals ARC Acquisition, $16.5B Bet on Future

Updated Category News Views 3

Shell’s Strategic Play: Snagging ARC When it comes to Shell, they don't dawdle with peanuts. Snagging ARC Resources Ltd., a Canadian energy firm rooted squarely in British Columbia and Alberta, speaks volumes about their appetite for growth. They’re shelling out approximately US$16.5 billion to pull this deal off the ground. This isn't just some casual sector play; it...

Continue Reading
Balázs Nagy's Bold Move: Transforming AI Workforce

Updated Category News Views 1

New Horizons in AI: Balázs Nagy Leads There's always that one name that shakes things up, and today it's Balázs Nagy. The guy's not just playing in the AI sandbox; he's leveling the whole thing up with Project NoéMI. He's the big cheese at TheNewPush LLC, beyond just a job title. Nagy’s diving headfirst into AI workforce development in a world screaming for change....

Continue Reading
BRP's C-Suite Shakeup: What It Means for Investors

Updated Category News Views 0

Passing the Baton in BRP's Financial Helm Alright, folks, grab your coffee and listen up. There's a shakeup coming from the cold corners of Valcourt, Quebec—BRP Inc., the powersports behemoth on the TSX: DOO, has announced a changing of the guard in their finance department. Come October 1st, there's a planned power shift as Sébastien Martel steps down as CFO, passing...

Continue Reading
Moore and RMI Forge Alliance for Data-Driven Success

Updated Category News Views 1

RMI and Moore Team Up for Strategic Evolution Let me tell ya, RMI Direct Marketing deciding to join forces with Moore’s AudienceFirst Media is a decision that’ll ripple through the data-driven waters for quite some time. They ain’t merging, mind you, but they’re definitely tying their ships together with a shared compass set on list management and brokerage...

Continue Reading
Dr. Anastasatos to Speak on Endoscopic Brow Lift in Crete

Updated Category News Views 3

Conference Spotlight: Endoscopic Brow Lift Plastic surgeons from across the globe are gathering in Crete, Greece, for a conference that promises to shake up the aesthetic world. Among the big names is Dr. John M. Anastasatos, who'll be lifting more than just eyebrows with his presentation on the endoscopic brow lift. This isn't just another facelift spiel—no sir—this...

Continue Reading

Top 5 Most Recently Viewed Articles

SEALSQ Boosts eSIM Adoption for Telcos with Secure Solutions

Updated Category News Views 169

SEALSQ Aids Telcos in Speeding Up eSIM Adoption SEALSQ provides a comprehensive solution that simplifies processes for eUICC manufacturers and SM-DP+/SM-DS service providers. This streamlining enables a quicker time to market through a cost-effective and simplified design approach for obtaining GSMA PKI Certificates. Progress in eSIM Technology SEALSQ Corp (NASDAQ: LAES)...

Continue Reading
Ontex's Strategic Share Buyback Program Overview

Updated Category News Views 113

Ontex's Strategic Share Buyback Program Ontex is making headlines with its ongoing program to acquire treasury shares, which marks a significant move for the company. The decision to initiate this buyback was formally disclosed in accordance with the regulations established by the Belgian government. This proactive strategy is designed to enhance shareholder value and...

Continue Reading
Rob Kole Named Co-Managing Partner at Choate Hall & Stewart

Updated Category News Views 143

Rob Kole Appointed Co-Managing Partner of Choate Hall & Stewart In a pivotal move for Choate Hall & Stewart LLP, Rob Kole has officially taken the role of co-managing partner within the esteemed law firm. With a career rooted in the firm itself, Kole brings a wealth of experience and expertise, having served in numerous capacities including practice group leader and...

Continue Reading
StakingBonus Introduces Comprehensive Ethereum Staking Solutions

Updated Category News Views 89

StakingBonus Launches Comprehensive Ethereum Staking Plans StakingBonus, a prominent name in the cryptocurrency staking industry, has recently rolled out a groundbreaking Ethereum staking plan. This innovative initiative aims to cater to both retail and institutional investors who are eager to engage in Ethereum staking. As Ethereum continues to evolve, the platform...

Continue Reading
New Heights for NYMTM Stock: Insights on Recent Growth

Updated Category News Views 52

Navigating the Rise of NYMTM Stock In a remarkable turn of events, New York Mortgage Trust Inc Preferred (NASDAQ: NYMTM) stock has reached a notable milestone by hitting a 52-week high, reflected by its price point of $24.55. This impressive performance signifies not only a strong market resurgence but also highlights the growing confidence investors have in the company....

Continue Reading